The support of human genetic evidence for approved drug indications
Top Cited Papers
- 29 June 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 47 (8), 856-860
- https://doi.org/10.1038/ng.3314
Abstract
Over a quarter of drugs that enter clinical development fail because they are ineffective. Growing insight into genes that influence human disease may affect how drug targets and indications are selected. However, there is little guidance about how much weight should be given to genetic evidence in making these key decisions. To answer this question, we investigated how well the current archive of genetic evidence predicts drug mechanisms. We found that, among well-studied indications, the proportion of drug mechanisms with direct genetic support increases significantly across the drug development pipeline, from 2.0% at the preclinical stage to 8.2% among mechanisms for approved drugs, and varies dramatically among disease areas. We estimate that selecting genetically supported targets could double the success rate in clinical development. Therefore, using the growing wealth of human genetic data to select the best targets and indications should have a measurable impact on the successful development of new drugs.This publication has 22 references indexed in Scilit:
- Genic Intolerance to Functional Variation and the Interpretation of Personal GenomesPLoS Genetics, 2013
- The Comparative Toxicogenomics Database: update 2013Nucleic Acids Research, 2012
- Annotation of functional variation in personal genomes using RegulomeDBGenome Research, 2012
- Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survivalDrug Discovery Today, 2012
- Use of genome-wide association studies for drug repositioningNature Biotechnology, 2012
- GWASdb: a database for human genetic variants identified by genome-wide association studiesNucleic Acids Research, 2011
- Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility lociAnnals of Neurology, 2011
- A map of human genome variation from population-scale sequencingNature, 2010
- Common variants at 30 loci contribute to polygenic dyslipidemiaNature Genetics, 2008
- Mapping the Genetic Architecture of Gene Expression in Human LiverPLoS Biology, 2008